Animal Model Market By Animal Type (Cats, Pigs, Mice), Application (Research and Development, Production and Quality Control, Academics), By End-User (Research Institutes, Pharmaceutical Companies), & Region for 2024-2031

Animal Model Market Valuation – 2024-2031

Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is propelling the adoption of Animal Model. They play a critical role in preclinical studies for testing the efficacy, safety, and pharmacokinetics of new drugs and therapies is driving the market size surpass USD 24.17 Billion valued in 2024 to reach a valuation of around USD 49.36 Billion by 2031.

In addition to this, Collaborations between academic institutions, pharmaceutical companies, and research organizations drive innovation in animal model development, supported by funding initiatives and grants that promote interdisciplinary research and infrastructure development is enabling the market grow at a CAGR of 10.3% from 2024 to 2031.

Animal Model MarketDefinition/ Overview

Animal models refer to living organisms, typically non-human species such as mice, rats, rabbits, and primates, used in scientific research to study biological processes, diseases, and potential therapies. They serve as experimental models to simulate human conditions, offering insights into physiology, genetics, and responses to treatments that are crucial for advancing medical and biological sciences.

Animal models are extensively used in biomedical research for various applications. They play a fundamental role in studying disease mechanisms, testing drug efficacy and safety, evaluating medical devices, understanding genetic disorders, and developing therapeutic interventions. These models are essential in disciplines such as oncology, immunology, neuroscience, toxicology, and infectious diseases, where they provide valuable data that informs clinical trials and medical treatments.

The future of animal models lies in advancing their relevance, reliability, and ethical use in scientific research. Technological innovations like genetic modification, organoid cultures, and bioinformatics are expected to enhance the accuracy and predictability of animal models in mimicking human diseases.

How will Biomedical Research Advancements Increase Adoption of Animal Model?

Animal models serve as critical tools for studying complex biological processes, disease mechanisms, and potential therapies that are difficult to replicate in vitro. They play a crucial role in advancing understanding across various fields such as oncology, neuroscience, immunology, and infectious diseases, providing valuable insights that contribute to medical breakthroughs and innovations.

Advances in genetic engineering, including the development of genetically modified animals and genome editing techniques like CRISPR-Cas9, have revolutionized the precision and relevance of animal models. These technologies allow researchers to create models that more accurately mimic human diseases and conditions, enhancing their utility in biomedical research and drug testing.

Collaborations between academic institutions, pharmaceutical companies, and government agencies drive innovation in animal model research. Funding initiatives, grants, and partnerships support the development of new models, promote interdisciplinary research, and foster infrastructure for animal facilities, thereby expanding the scope and applications of animal models in advancing biomedical knowledge and therapeutic development.

Will Ethical Concerns and Animal Welfare Restrain Animal Model Market?

The use of animals in research raises ethical considerations regarding animal welfare, suffering, and moral objections from advocacy groups and the general public. Increasing awareness and scrutiny regarding animal rights have led to calls for reduced animal experimentation and the development of alternative methods, posing challenges to the widespread acceptance and use of animal models.

Regulatory frameworks governing animal research impose stringent requirements for ethical approval, animal care standards, and reporting of experimental outcomes. Compliance with these regulations adds complexity and costs to conducting research using animal models, requiring extensive documentation, oversight, and adherence to guidelines set forth by regulatory bodies.

Also, despite their utility, animal models may not always accurately replicate human biology or predict clinical outcomes. Differences in genetic backgrounds, physiology, and disease mechanisms between animals and humans can limit the translatability of preclinical findings, leading to challenges in extrapolating results to human populations and clinical settings.

Category-Wise Acumens

Which Factors Contributing Mice Segment Growth in Animal Model Market?

The cloud-based segment is anticipated to hold a major share in the Animal Model market. The increasing adoption of cloud computing is underscoring a transformative shift in organizations management and tracking of workforce attendance. This technology is gaining momentum among the businesses focusing on modernization, scalability, and agile solutions to meet the evolving demands of the workplace.

The accessibility and flexibility offered by cloud-based Animal Model to centralize attendance management for a global workforce helps employees to conveniently access the system from any location with an internet connection, accommodating the increasing prevalence of remote work and flexible schedules. Also, the automatic updates and maintenance inherent to cloud-based systems ensures that organizations benefit from the latest features and security enhancements without disrupting daily operations.

The cost-savings associated with the use of subscription-based models by eliminating the need for organizations to manage and maintain complex hardware setups is making cloud-based time attendance systems a secure choice for organizations. Besides these, real-time data access and analysis empowered by cloud-based Animal Model is facilitating faster decision-making and more effective workforce management for the HRs and organizations.

Which Factors Enhance the Use of Animal Model in Research and Development?

R&D efforts in the animal model market focus on expanding our understanding of complex biological processes, disease mechanisms, and therapeutic interventions. Animal models serve as essential tools for studying human diseases such as cancer, cardiovascular disorders, neurodegenerative diseases, and infectious diseases. By simulating disease conditions in animals, researchers can uncover fundamental insights into disease progression, biomarker identification, and treatment efficacy, driving advancements in medical science.

R&D in animal models is critical for preclinical testing of new pharmaceutical compounds and therapies. These models enable researchers to evaluate drug efficacy, pharmacokinetics, and safety profiles before human trials, helping to identify promising candidates for further development. The ability to mimic human disease conditions in animals enhances the predictive value of preclinical studies, accelerating the drug discovery process and reducing the risk of adverse effects in clinical trials.

R&D initiatives in the animal model market are guided by regulatory requirements and standards governing animal research. Regulatory compliance ensures ethical treatment of animals, adherence to animal welfare guidelines, and rigorous reporting of experimental outcomes. Standardization of experimental protocols and animal care practices promotes consistency in research methodologies, enhances data reproducibility, and facilitates comparative studies across different research institutions and laboratories.

Gain Access into Animal Model Market Report Methodology

Country/Region-wise Acumens

Will Advanced Biomedical Research Infrastructure in North America Mature Animal Model Market?

North America boasts robust biomedical research infrastructure, including world-renowned academic institutions, research centers, and pharmaceutical companies. These entities conduct extensive research using animal models to advance understanding of disease mechanisms, develop therapies, and innovate biomedical technologies.

The region’s stringent regulatory frameworks, such as those set by the FDA in the United States and Health Canada, govern the ethical use of animal models in research. Compliance with these standards ensures high ethical standards, animal welfare, and scientific rigor in preclinical studies, bolstering confidence in research outcomes and supporting translation to clinical applications.

North America leads in technological innovations, particularly in genetic engineering techniques like CRISPR-Cas9. These advancements enable the creation of sophisticated genetically modified animal models that better mimic human diseases, enhancing the relevance and reliability of preclinical research outcomes.

Will Rising Pharmaceutical and Biotechnology Sector Enhance Adoption of Animal Model in Asia Pacific?

The region’s burgeoning pharmaceutical and biotechnology industries are driving demand for animal models in drug discovery and development. Rapid economic growth, increasing healthcare expenditures, and rising prevalence of chronic diseases fuel the need for innovative therapeutic solutions. Animal models play a crucial role in preclinical studies, helping researchers evaluate drug efficacy, safety profiles, and pharmacokinetics before advancing to clinical trials.

Asia Pacific is at the forefront of technological advancements in genetic engineering and biomedical research tools. The adoption of cutting-edge techniques such as CRISPR-Cas9 and the development of genetically modified animal models enhance the region’s capabilities in modeling human diseases more accurately. These advancements improve the translatability of preclinical findings, supporting the development of targeted therapies and personalized medicine approaches.

Collaborative efforts between academia, industry, and government sectors are fostering innovation and knowledge exchange in the animal model market. Partnerships facilitate the sharing of resources, expertise, and infrastructure, accelerating research outcomes and enhancing competitiveness on a global scale. The region’s dynamic research ecosystem and growing scientific expertise position Asia Pacific as a key player in shaping the future of biomedical research and therapeutic development using animal models.

Competitive Landscape

The competitive landscape of the animal model market is characterized by a diverse array of suppliers, contract research organizations (CROs), and academic institutions globally. These entities compete based on their expertise in providing specialized animal models, research services, and facilities tailored to the needs of pharmaceutical, biotechnology, and academic research sectors. Differentiated by their research capabilities, ethical standards, regulatory compliance, and technological advancements, companies in the competitive landscape strive to offer comprehensive solutions that support preclinical studies and therapeutic development. Collaboration and strategic partnerships further shape the competitive dynamics, facilitating innovation and expanding market reach in the evolving field of biomedical research using animal models. Some of the prominent players operating in the Animal Model market include

• Charles River Laboratories International, Inc.
• Envigo
• Taconic Biosciences
• The Jackson Laboratory
• Janvier Labs
• Harlan Laboratories (part of Envigo)
• Covance Inc. (a Labcorp company)
• Crown Bioscience Inc.
• genOway S.A.
• Axcelead Drug Discovery Partners, Inc.
• Eurofins Scientific
• Transposagen Biopharmaceuticals, Inc.
• Horizon Discovery Group plc
• SAGE Labs (part of Horizon Discovery)
• Pharmaron
• Wuxi AppTec
• InVivos Pte Ltd.
• Vivo Bio Tech Ltd.
• Beijing VitalStar Biotechnology Co., Ltd.
• Cyagen Biosciences Inc.

Latest Developments

• In April 2021, Horizon Discovery has secured a multi-license commercial agreement with IGM Biosciences, a clinical-stage biotechnology company specializing in engineered IgM antibodies, to continue using Horizon’s cGMP-compliant CHO SOURCE platform for further development of IGM’s therapeutic IgM antibodies within two years of their first license.
• In January 2020, Horizon Discovery Group has partnered with Mammoth Biosciences to develop a new generation of genetically engineered CHO cells for the production of biotherapeutics like therapeutic antibodies. The collaboration will allow Horizon to access Mammoth’s novel CRISPR platform, enabling the delivery of genetically engineered CHO cells.

Report Scope

Animal Model Market, By Category

Animal Type

• Cats
• Pigs
• Mice
• Monkeys

Application

• Research and Development
• Production and Quality Control
• Academics

End-Users

• Research Institutes
• Pharmaceutical Companies
• CRO (Contract Research Organizations)
• Educational Institutes

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.